Stonepine Capital Management »

Bioatla shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Bioatla shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Bioatla

Tip: Access up to 7 years of quarterly data

All positions including Bioatla held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioatla by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $11k 65k 0.16

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Evolus (EOLS)
Camp4 Therapeutics Corp (CAMP)
Nektar Therapeutics Com New (NKTR)
Terns Pharmaceuticals Call Option (TERN)
Zevra Therapeutics Com New (ZVRA)
Abeona Therapeutics Com New (ABEO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Establishment Labs Holdings Ord Call Option (ESTA)
Kazia Therapeutics Sponsored Ads (KZIA)
An2 Therapeutics (ANTX)
Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Bioatla

Acorn Capital Advisors
Millennium Management
Vanguard Capital Management
Acadian Asset Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Renaissance Technologies
BlackRock
Citadel Advisors
UBS Group
Vanguard Fiduciary Trust
ADAR1 Capital Management
State Street Corporation
Northern Trust
Jane Street

View all funds holding Bioatla